Doctors may be able to treat rare blood clots linked to the coronavirus vaccine easier after new guidance was issued by UK scientists.
A team of experts at Oxford University Hospital’s NHS Foundation Trust have identified markers that can help diagnose vaccine-induced immune thrombocytopenia and thrombosis (Vitt).
Thrombocytopenia is a condition where the patient has a low count of cells that help the blood clot, known as platelets. Thrombosis occurs when blood clots block veins or arteries and can lead to life-threatening conditions such as a stroke or heart attack.
Read more on dailyrecord.co.uk